Cargando…
miR‐31 ameliorates type 2 diabetic vascular damage through up‐regulation of hypoxia‐inducible factor‐1α/vascular endothelial growth factor‐A
AIMS: microRNA may be a new therapeutic direction for diabetes. As a typical tumor marker, miR‐31 is involved in a variety of metabolic diseases, but the specific role is still unclear. This study aimed to investigate the effect of miR‐31 on type 2 diabetes mellitus and its accompanying vascular inj...
Autores principales: | Fu, Yuan, Du, Ruochen, Wang, Yufei, Yuan, Yitong, Zhang, Yujuan, Wang, Chunfang, Zhang, Xuanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445209/ https://www.ncbi.nlm.nih.gov/pubmed/37394926 http://dx.doi.org/10.1111/jdi.14039 |
Ejemplares similares
-
MiR-31 improves spinal cord injury in mice by promoting the migration of bone marrow mesenchymal stem cells
por: Zhang, Yujuan, et al.
Publicado: (2022) -
Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats
por: Wang, Zhang, et al.
Publicado: (2013) -
Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2014) -
Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2015) -
Vascular endothelial growth factor suppresses TNFSF15 production in endothelial cells by stimulating miR‐31 and miR‐20a expression via activation of Akt and Erk signals
por: Deng, Hui‐Ting, et al.
Publicado: (2016)